Annual Shareholders Equity
$5.37 M
-$3.76 M-41.19%
March 1, 2024
Summary
- As of February 26, 2025, VRAX annual stockholders equity is $5.37 million, with the most recent change of -$3.76 million (-41.19%) on March 1, 2024.
- During the last 3 years, VRAX annual shareholders equity has risen by +$6.02 million (+924.77%).
- VRAX annual shareholders equity is now -41.19% below its all-time high of $9.13 million, reached on March 31, 2023.
Performance
VRAX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$8.64 M
+$3.28 M+61.08%
September 1, 2024
Summary
- As of February 26, 2025, VRAX quarterly stockholders equity is $8.64 million, with the most recent change of +$3.28 million (+61.08%) on September 1, 2024.
- Over the past year, VRAX quarterly shareholders equity has stayed the same.
- VRAX quarterly shareholders equity is now -5.27% below its all-time high of $9.13 million, reached on March 31, 2023.
Performance
VRAX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VRAX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.2% | 0.0% |
| 3 y3 years | +924.8% | 0.0% |
| 5 y5 years | +608.2% | 0.0% |
VRAX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.2% | +650.7% | -5.3% | +987.0% |
| 5 y | 5-year | -41.2% | +608.2% | -5.3% | +987.0% |
| alltime | all time | -41.2% | +608.2% | -5.3% | +987.0% |
Virax Biolabs Group Limited Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.64 M(+61.1%) |
| Mar 2024 | $5.37 M(-41.2%) | $5.37 M(-15.3%) |
| Sep 2023 | - | $6.33 M(-30.6%) |
| Mar 2023 | $9.13 M | $9.13 M(+107.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.39 M(-550.7%) |
| Mar 2022 | -$974.60 K(+49.8%) | -$974.60 K(+22.0%) |
| Sep 2021 | - | -$798.90 K(+22.8%) |
| Mar 2021 | -$650.70 K(-38.4%) | -$650.70 K |
| Mar 2020 | -$1.06 M | - |
FAQ
- What is Virax Biolabs Group Limited annual stockholders equity?
- What is the all time high annual shareholders equity for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual shareholders equity year-on-year change?
- What is Virax Biolabs Group Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited quarterly shareholders equity year-on-year change?
What is Virax Biolabs Group Limited annual stockholders equity?
The current annual shareholders equity of VRAX is $5.37 M
What is the all time high annual shareholders equity for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual stockholders equity is $9.13 M
What is Virax Biolabs Group Limited annual shareholders equity year-on-year change?
Over the past year, VRAX annual stockholders equity has changed by -$3.76 M (-41.19%)
What is Virax Biolabs Group Limited quarterly stockholders equity?
The current quarterly shareholders equity of VRAX is $8.64 M
What is the all time high quarterly shareholders equity for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high quarterly stockholders equity is $9.13 M
What is Virax Biolabs Group Limited quarterly shareholders equity year-on-year change?
Over the past year, VRAX quarterly stockholders equity has changed by $0.00 (0.00%)